- Citations, last 5 years
- 74.3k
- Works, last 5 years
- 5 794
- h-index
- 1,073
- Scientists listed
- 1 131
- Grants since 2016
- 2 609
Grants received
2017–2022 · research · R01
Molecular Basis of Photoreceptor Wiring
Kirill A. Martemyanov · Scripps Research Institute · funded by National Institutes of Health
2017–2018 · fellowship · Postdoctoral Fellowship
Targeted and activity-regulated plasminogen activators as catalytic therapeutics
Purba Mukherjee · Scripps Research Institute · funded by American Heart Association
2017–2020 · fellowship · F32
Can Autophagy and Lipid Homeostasis be Modulated by Unfolded Protein Response Activation?
Christian M Cole · Scripps Research Institute · funded by National Institutes of Health
2017–2020 · career development · K99
Alcohol-induced neuroadapation of prefrontal cortical projections
Florence Prabha Varodayan · Scripps Research Institute · funded by National Institutes of Health
2017–2019 · research · R01
A Virus-Free Cell Platform To Discover Inhibitors Of Lassa Fever Virus
Juan C. De La Torre · Scripps Research Institute · funded by National Institutes of Health
2017–2019 · research · R21
Discovery of Potent Proteasome Agonists to Improve Proteostasis
Thomas J. Kodadek · Scripps Research Institute · funded by National Institutes of Health
2017–2022 · cooperative agreement · U01
Identification of Genetic Variants that Contribute to Compulsive Cocaine Intake in Rats
Olivier George · Scripps Research Institute · funded by National Institutes of Health
2017–2020 · research · R01
Visualizing epithelial network connectivity in thymus biology, aging, and regeneration
Dawen Cai · Scripps Research Institute · funded by National Institutes of Health
2017–2021 · research · R01
Biology of α-linked glycosylceramides in the immune system
Luc Teyton · Scripps Research Institute · funded by National Institutes of Health
2017–2027 · research · R35
Unusual Pharmacophores and New Tools for Cross-Coupling
Ryan Ashok Shenvi · Scripps Research Institute · funded by National Institutes of Health
2017–2019 · research · R21
Development and validation of a genetically engineered model of neurofibromatosis type 2 to facilitate discovery of neurotherapeutics
Joseph Kissil · Scripps Research Institute · funded by National Institutes of Health
2017–2022 · cooperative agreement · U01
PTPN22 R619W in NOD mice
Linda A Sherman · Scripps Research Institute · funded by National Institutes of Health
2017–2019 · career development · K99
Mapping druggable co-dependency pathways in NRF2-driven lung cancers
Liron Bar-Peled · Scripps Research Institute · funded by National Institutes of Health
2017–2024 · research · R01
S-Nitrosylation-Induced Posttranslational Modification and Aberrant Cell Signaling in Sporadic Alzheimer's Disease
Stuart A Lipton · Scripps Research Institute · funded by National Institutes of Health
2017–2021 · research · R01
Molecular and Cellular Mechanisms of the Lysosomal Storage Disease Cystinosis
Sergio Daniel Catz · Scripps Research Institute · funded by National Institutes of Health
2017–2023 · research · R01
A Unique Class of Reductively Activated Oncology Drugs
Dale L Boger · Scripps Research Institute · funded by National Institutes of Health
2017–2020 · research · R01
Molecular and Cellular Mechanisms of the Lysosomal Storage Disease Cystinosis
Sergio Daniel Catz · Scripps Research Institute · funded by National Institutes of Health
2017–2022 · research · R01
Biology of α-linked glycosylceramides in the immune system
Luc Teyton · Scripps Research Institute · funded by National Institutes of Health
2017–2025 · research · R35
Mechanisms of force sensing in the nervous system
Ardem Patapoutian · Scripps Research Institute · funded by National Institutes of Health
2017–2022 · cooperative agreement · U01
Proof-of-Concept Human Laboratory Testing of Novel Drug Candidates Identified by INIA-NeuroImmune
Barbara J Mason · Scripps Research Institute · funded by National Institutes of Health
2017–2022 · program · P01
Pathophysiology of genetically defined dementia and neurodegeneration: Defining therapeutic targets and pathways
Matthew D Disney · Scripps Research Institute · funded by National Institutes of Health
2017–2019 · fellowship · Postdoctoral Fellowship
A Novel Approach to Trigger Body Fat Loss via the ATGL Triglyceride Lipase
Nicole Littlejohn · Scripps Research Institute · funded by American Heart Association
2017–2022 · research · R35
Combinatorial, Catalytic Functionalization of Alkenes and Alkynes
Keary Mark Engle · Scripps Research Institute · funded by National Institutes of Health
2017–2018 · research · R01
Development of assays for HTS to identify inhibitors of a new PPI involved in cancer metastasis
Celine Dermardirossian · Scripps Research Institute · funded by National Institutes of Health
2017–2019 · fellowship · F32
Chemical Strategies to Probe the Mechanism of Liposomal Tucaresol Immunopotentiation in a Drug of Abuse Vaccine
Margaret Emily Olson · Scripps Research Institute · funded by National Institutes of Health
2017–2023 · research · R01
Impacting Cell Growth through altered circadian proteolysis
Katja A Lamia · Scripps Research Institute · funded by National Institutes of Health
2017–2022 · research · R01
Mechanisms of Nf1 pathophysiology underlying hyperactivity
Seth M Tomchik · Scripps Research Institute · funded by National Institutes of Health
2017–2020 · fellowship · F31
Broadening autologous Tier 2 anti-HIV neutralizing antibodies
Christopher Andrew Cottrell · Scripps Research Institute · funded by National Institutes of Health
2017–2022 · cooperative agreement · U01
PTPN22 R619W in NOD mice
Linda A Sherman · Scripps Research Institute · funded by National Institutes of Health
2017–2020 · research · R01
Visualizing epithelial network connectivity in thymus biology, aging, and regeneration
Dawen Cai · Scripps Research Institute · funded by National Institutes of Health
2017–2021 · research · R01
Glycoprotein Ib in vascular biology and host defense
Zaverio M Ruggeri · Scripps Research Institute · funded by National Institutes of Health
2017–2022 · program · P01
Pathophysiology of genetically defined dementia and neurodegeneration: Defining therapeutic targets and pathways
Matthew D Disney · Scripps Research Institute · funded by National Institutes of Health
2017–2020 · research · R01
Development of assays for HTS to identify inhibitors of a new PPI involved in cancer metastasis
Celine Dermardirossian · Scripps Research Institute · funded by National Institutes of Health
2017–2027 · research · R35
Unusual Pharmacophores and New Tools for Cross-Coupling
Ryan Ashok Shenvi · Scripps Research Institute · funded by National Institutes of Health
2017–2022 · research · R35
Unusual Pharmacophores and New Tools for Cross-Coupling
Ryan Ashok Shenvi · Scripps Research Institute · funded by National Institutes of Health
2017–2020 · fellowship · F32
Can Autophagy and Lipid Homeostasis be Modulated by Unfolded Protein Response Activation?
Christian M Cole · Scripps Research Institute · funded by National Institutes of Health
2017–2019 · research · R36
Functional circuitry supporting PTSD-like symptoms in male and female mice
Nadine Florence Joseph · Scripps Research Institute · funded by National Institutes of Health
2017–2022 · research · R35
Unusual Pharmacophores and New Tools for Cross-Coupling
Ryan Ashok Shenvi · Scripps Research Institute · funded by National Institutes of Health
2017–2022 · research · R35
Combinatorial, Catalytic Functionalization of Alkenes and Alkynes
Keary Mark Engle · Scripps Research Institute · funded by National Institutes of Health
2017–2022 · cooperative agreement · U01
PTPN22 R619W in NOD mice
Linda A Sherman · Scripps Research Institute · funded by National Institutes of Health
